Hidradenitis Suppurativa Pipeline Analysis Report 2024:
Dublin, May 03, 2024 (GLOBE NEWSWIRE) -- The
Source: globenewswire.com
Hurley Stage News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Hurley Stage. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Hurley Stage Today - Breaking & Trending Today
Hidradenitis Suppurativa: Sonelokimab Shows Promise in Study
Sonelokimab is a novel humanized nanobody that selectively binds to interleukin (IL)-17A and IL-17F.
Source: medscape.com
Drug Survival of Hidradenitis Suppurativa Patients Treated with Infliximab, Adalimumab
These findings from AAD 2024 did not include statistically significant infliximab response predictors, though it had been the largest reported cohort on the subject to date.
Source: hcplive.com
Lutikizumab Showed Positive Results in a Phase 2 Trial of Adults with Moderate to Severe Hidradenitis Suppurativa as Program Advances to Phase 3
Phase 2 data in adults with hidradenitis suppurativa (HS) who had previously failed anti-TNF therapy who received lutikizumab (ABT-981) 300 mg weekly or 300 mg...
Source: prnewswire.com
Lutikizumab Showed Positive Results in a Phase 2 Trial of Adults with Moderate to Severe Hidradenitis Suppurativa as Program Advances to Phase 3
Phase 2 data in adults with hidradenitis suppurativa (HS) who had previously failed anti-TNF therapy who received lutikizumab (ABT-981) 300 mg weekly or 300 mg every other week showed higher response rates in HiSCR 50 at week 16 than those treated...
Source: lelezard.com